![Quentin Langlois](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Quentin Langlois
Private Equity Investor chez
H.I.G. BioHealth Partners LLC
Profil
Quentin Langlois is currently a Vice President at H.I.G.
BioHealth Partners LLC since 2021.
Prior to this, he worked as an Associate Director at Theravance Biopharma US, Inc. from 2018 to 2021, a Sr Associate at aTyr Pharma, Inc. from 2014 to 2018, a Private Equity Analyst at Astorg Partners SAS in 2012, and an Analyst at Shire Pharmaceutical Development Ltd. in 2013.
Mr. Langlois holds an MBA from Instituto Tecnológico Autónomo de México and École des Hautes Études Commerciales de Paris, and an undergraduate degree from Université de Versailles Saint-Quentin-en-Yvelines, which he received in 2011.
Postes actifs de Quentin Langlois
| Sociétés | Poste | Début |
|---|---|---|
H.I.G. BioHealth Partners LLC
 H.I.G. BioHealth Partners LLC Investment ManagersFinance H.I.G. BioHealth Partners invests in small and middle companies located in the United States. The firm focuses on medical devices, biopharmaceuticals, digital health, tool & diagnostics and product related services. It participates in growth, acquisition and IPO in the form of equity and debt. The firm also makes follow-on investments. | Private Equity Investor | 01/01/2021 |
Anciens postes connus de Quentin Langlois
| Sociétés | Poste | Fin |
|---|---|---|
Theravance Biopharma US, Inc.
 Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Directeur/Membre du Conseil | 31/12/2021 |
| ATYR PHARMA, INC. | Analyste en capital-investissement | 31/12/2018 |
Shire Pharmaceutical Development Ltd.
 Shire Pharmaceutical Development Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of pharmaceutical products | Analyst-Equity | 31/12/2013 |
Astorg Partners SAS
 Astorg Partners SAS Investment ManagersFinance Astorg invests in companies located in the United States and Europe with an enterprise value of EUR 100 - 500 million. The firm targets companies operating in the fields of healthcare, software, business-to-business professional services and technology-based industrial companies. It provides financing for buyout transactions and also acquires minority, majority and controlling interest. | Analyste en capital-investissement | 31/12/2013 |
Formation de Quentin Langlois
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
Astorg Partners SAS
Astorg Partners SAS Investment ManagersFinance Astorg invests in companies located in the United States and Europe with an enterprise value of EUR 100 - 500 million. The firm targets companies operating in the fields of healthcare, software, business-to-business professional services and technology-based industrial companies. It provides financing for buyout transactions and also acquires minority, majority and controlling interest. | Finance |
Instituto Tecnológico Autónomo de México
 Instituto Tecnológico Autónomo de México Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
École des Hautes Études Commerciales de Paris
 École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université de Versailles Saint-Quentin-en-Yvelines
 Université de Versailles Saint-Quentin-en-Yvelines Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Pharmaceutical Development Ltd.
Shire Pharmaceutical Development Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of pharmaceutical products | Commercial Services |
H.I.G. BioHealth Partners LLC
H.I.G. BioHealth Partners LLC Investment ManagersFinance H.I.G. BioHealth Partners invests in small and middle companies located in the United States. The firm focuses on medical devices, biopharmaceuticals, digital health, tool & diagnostics and product related services. It participates in growth, acquisition and IPO in the form of equity and debt. The firm also makes follow-on investments. | Finance |
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Commercial Services |
